Your browser doesn't support javascript.
loading
Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease.
Østergaard, Jakob A; Jha, Jay C; Sharma, Arpeeta; Dai, Aozhi; Choi, Judy S Y; de Haan, Judy B; Cooper, Mark E; Jandeleit-Dahm, Karin.
Afiliación
  • Østergaard JA; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Jha JC; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Sharma A; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Dai A; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Choi JSY; Baker Heart and Diabetes Institute, Oxidative Stress Laboratory, Melbourne, Victoria, Australia.
  • de Haan JB; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Cooper ME; Baker Heart and Diabetes Institute, Oxidative Stress Laboratory, Melbourne, Victoria, Australia.
  • Jandeleit-Dahm K; Baker Heart and Diabetes Institute, Oxidative Stress Laboratory, Melbourne, Victoria, Australia.
Clin Sci (Lond) ; 136(2): 167-180, 2022 01 28.
Article en En | MEDLINE | ID: mdl-35048962

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sulfonamidas / Nefropatías Diabéticas / Inflamasomas / Proteína con Dominio Pirina 3 de la Familia NLR / Furanos / Indenos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Clin Sci (Lond) Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sulfonamidas / Nefropatías Diabéticas / Inflamasomas / Proteína con Dominio Pirina 3 de la Familia NLR / Furanos / Indenos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Clin Sci (Lond) Año: 2022 Tipo del documento: Article País de afiliación: Australia